CalciMedica, Inc. (CALC) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-04-07

Key Insights

The reporting person, A. Rachel Leheny, is the Chief Executive Officer and a 10% owner of CalciMedica, Inc.
Leheny acquired 148,482 stock options on April 5, 2025, with a strike price of $0.585 and an expiration date of April 4, 2036.
The options will vest in equal monthly installments over a four-year period starting April 1, 2026, subject to the filing of the company's registration statement on Form S-8.

Want the newest filings?

This analysis covers the filing from 2026-04-07. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-04-07

The reporting person, Kenneth A. Stauderman, acquired 65,124 employee stock options with an exercise price of $0.585 on 2025-04-05, vesting over a four-year period starting 2026-04-01.
The options granted to the Chief Scientific Officer indicate continued confidence in the company's long-term growth prospects.
The transaction is a routine insider option grant and does not signal any significant changes in the company's operations or financial condition.

Filed: 2026-04-07

Michael J. Dunn, the President and COO of CalciMedica, Inc. (CALC), acquired 65,124 stock options with a strike price of $0.585 and a four-year vesting period, indicating his confidence in the company's future performance.
The stock options were granted on April 5, 2025, and the vesting is contingent on the filing of the company's registration statement on Form S-8, which could provide additional shares for the equity incentive plan.
Insider buying, such as this option grant, can be a positive signal for investors, as it suggests management believes the company's stock is undervalued and has potential for growth.

Filed: 2026-04-07

Eric W. Roberts, the Chief Business Officer and a 10% owner of CalciMedica, Inc. (CALC), exercised 83,358 stock options at $0.585 per share on April 5, 2026, indicating his confidence in the company's future prospects.
The stock options granted to Eric W. Roberts vest over a four-year period, subject to the filing of a registration statement on Form S-8 covering the shares added to the company's equity incentive plan on January 1, 2026, suggesting a long-term commitment to the company.
The exercise of stock options by a key insider like the Chief Business Officer and a significant shareholder could be a positive signal for investors, as it may indicate management's belief in the company's growth potential.

Filed: 2026-04-07

Insider Sudarshan Hebbar, the Chief Medical Officer, acquired 91,173 stock options of CalciMedica, Inc. (CALC) at an exercise price of $0.585 per share.
The options vest over a four-year period, with the first shares vesting on April 4, 2036, subject to the filing of a registration statement on Form S-8 covering the additional shares authorized under the company's equity incentive plan.
This transaction suggests Hebbar's confidence in the company's future prospects and aligns his interests with those of other shareholders.

Filed: 2026-04-07

Stephen Bardin, the Chief Financial Officer of CalciMedica, Inc., exercised 67,728 stock options with an exercise price of $0.585 per share, indicating his confidence in the company's future prospects.
The vesting of the stock options is subject to the filing of the company's registration statement on Form S-8, which suggests an upcoming equity incentive plan update or expansion.
Insider transactions, such as this option exercise, can provide insight into management's view of the company's valuation and growth potential.

Other reports for CalciMedica, Inc.

Current Report Annual Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.